We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Fields »
 

Field

Term
Gene name

Class

Subclass

Chromosome

External id

In atlas

Reliability

Reliability

Reliability

Validation

Method

Validation

Method

Validation

Method

Validation

Location

Searches

Tissue

Cell type

Expression

Tissue

Specificity

Cell line

Specificity

Cancer

Specificity

Tissue

Detectable

Cell line

Detectable

Cancer

Detectable

Cancer

Prognosis

Category

Score

Score

Score

Antibodies

Column

 
 
ABOUT
HELP
BLOG
  • THE HUMAN PROTEOME
  • THE HUMAN TISSUES
  • THE HUMAN CELL
  • HUMAN PATHOLOGY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
    • NEWS
    • BLOG
    • EVENTS
    • PRESS ROOM
    • LEARN
    • DICTIONARY
    • METHODS
    • CELL LINES
  • THE PROJECT
  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • PUBLICATION DATA
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • LINKS
  • CONTACT
  • TECHNICAL DATA
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • DOWNLOADABLE DATA
  • HELP & FAQ
  • LICENCE & CITATION
  • PRIVACY STATEMENT
  • RELEASE HISTORY
EXOSC10
  • premium

    TISSUE

  • premium

    CELL

  • PATHOLOGY

PATHOLOGY ATLAS

GENE/PROTEIN

Antibody validation

Dictionary

Level of antibody staining/expression





High
Medium
Low
Not detected

GENERAL INFORMATION

Gene name

EXOSC10

Gene description

Exosome component 10

Protein class

Predicted intracellular proteins

Predicted localization

Intracellular

Number of transcripts

2
SHOW MORE

HUMAN PROTEIN ATLAS INFORMATION

RNA category

TCGA (cancer tissue):Expressed in all
HPA (cell line):Expressed in all
HPA (normal tissue):Expressed in all

Protein evidence

Evidence at protein level

Protein expression
normal tissue

General nucleolar expression.

ANTIBODY IHC RELIABILITY

Data reliability
description

Antibody staining mainly consistent with RNA expression data.

Reliability score

Supported based on 3 antibodies.
HPA028470 , HPA028484 , CAB037141
SHOW MORE

PROGNOSTIC SUMMARY

Prognostic marker in liver cancer (unfavourable) and thyroid cancer (favourable).
Liver cancer p<0.001
Thyroid cancer p<0.001
Show all

RNA EXPRESSION OVERVIEW

TCGA dataset
RNA cancer category: Expressed in all

PROTEIN EXPRESSION

Colorectal cancer
Breast cancer
Prostate cancer
Lung cancer
Skin cancer

STAINING SUMMARY

HPA028470
HPA028484
CAB037141

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

A majority of cancer cells displayed moderate to strong nucleolar immunoreactivity. Most gliomas, renal, endometrial, urothelial, pancreatic and liver cancers were weakly stained or negative.

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Most cancer tissues displayed moderate cytoplasmic and nuclear positivity. Thyroid adenocarcinomas and occasional cases of cervical cancers exhibited strong immunoreactivity. Several cases of gliomas, lymphomas, lung and renal cancers displayed weak staining or were negative.

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Cancer tissues displayed moderate to strong nuclear staining with additional cytoplasmic positivity in few cases. Several cases of gliomas, lymphomas, renal and liver cancers were weakly stained or negative.

GENE INFORMATION

Gene name

EXOSC10 (HGNC Symbol)

Synonyms

p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p

Description

Exosome component 10 (HGNC Symbol)

Entrez gene summary

Chromosome

1

Cytoband

p36.22

Chromosome location (bp)

11066618 - 11099881

Protein evidence

Evidence at protein level (all genes)

Ensembl

ENSG00000171824 (version 83.38)

Entrez gene

5394

UniProt

Q01780 (UniProt - Evidence at protein level)

neXtProt

NX_Q01780

Antibodypedia

EXOSC10 antibodies

PROTEIN BROWSER

EXOSC10-001
EXOSC10-002

PROTEIN INFORMATION

Splice variant

UniProt

Protein class

Gene ontology

Length & mass

Signal peptide
(predicted)

Transmembrane regions
(predicted)

EXOSC10-001
ENSP00000366135
ENST00000376936
Q01780 [Direct mapping]
Exosome component 10
Show all
Predicted intracellular proteins
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000166 [nucleotide binding]
GO:0000176 [nuclear exosome (RNase complex)]
GO:0000178 [exosome (RNase complex)]
GO:0000184 [nuclear-transcribed mRNA catabolic process, nonsense-mediated decay]
GO:0000460 [maturation of 5.8S rRNA]
GO:0000956 [nuclear-transcribed mRNA catabolic process]
GO:0003676 [nucleic acid binding]
GO:0003824 [catalytic activity]
GO:0004532 [exoribonuclease activity]
GO:0005515 [protein binding]
GO:0005622 [intracellular]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0006139 [nucleobase-containing compound metabolic process]
GO:0006396 [RNA processing]
GO:0008408 [3'-5' exonuclease activity]
GO:0009048 [dosage compensation by inactivation of X chromosome]
GO:0016020 [membrane]
GO:0035327 [transcriptionally active chromatin]
GO:0044237 [cellular metabolic process]
GO:0044822 [poly(A) RNA binding]
GO:0071028 [nuclear mRNA surveillance]
GO:0071034 [CUT catabolic process]
GO:0071035 [nuclear polyadenylation-dependent rRNA catabolic process]
GO:0071044 [histone mRNA catabolic process]
GO:0071048 [nuclear retention of unspliced pre-mRNA at the site of transcription]
GO:0090503 [RNA phosphodiester bond hydrolysis, exonucleolytic]
Show all
885 aa
100.8 kDa
No 0
EXOSC10-002
ENSP00000307307
ENST00000304457
Q01780 [Direct mapping]
Exosome component 10
Show all
Predicted intracellular proteins
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000166 [nucleotide binding]
GO:0000176 [nuclear exosome (RNase complex)]
GO:0000178 [exosome (RNase complex)]
GO:0000184 [nuclear-transcribed mRNA catabolic process, nonsense-mediated decay]
GO:0000460 [maturation of 5.8S rRNA]
GO:0000956 [nuclear-transcribed mRNA catabolic process]
GO:0003676 [nucleic acid binding]
GO:0003824 [catalytic activity]
GO:0004532 [exoribonuclease activity]
GO:0005515 [protein binding]
GO:0005622 [intracellular]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0006139 [nucleobase-containing compound metabolic process]
GO:0006396 [RNA processing]
GO:0008408 [3'-5' exonuclease activity]
GO:0016020 [membrane]
GO:0035327 [transcriptionally active chromatin]
GO:0044237 [cellular metabolic process]
GO:0044822 [poly(A) RNA binding]
GO:0071028 [nuclear mRNA surveillance]
GO:0071034 [CUT catabolic process]
GO:0071035 [nuclear polyadenylation-dependent rRNA catabolic process]
GO:0071044 [histone mRNA catabolic process]
GO:0071048 [nuclear retention of unspliced pre-mRNA at the site of transcription]
GO:0090503 [RNA phosphodiester bond hydrolysis, exonucleolytic]
Show all
860 aa
98.1 kDa
No 0

Contact

  • BLOG
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • DOWNLOADABLE DATA

The Human Protein Atlas

  • ANTIBODY AVAILABILITY
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.